Discovery Laboratories, Inc. (NASDAQ:DSCO)

CAPS Rating: 3 out of 5

A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.

Recs

1
Player Avatar schuured (97.87) Submitted: 12/6/2011 10:57:14 AM : Outperform Start Price: $2.15 DSCO Score: +20.19

Completely speculative.

Featured Broker Partners


Advertisement